Alphatec Holdings Inc
NASDAQ:ATEC

Watchlist Manager
Alphatec Holdings Inc Logo
Alphatec Holdings Inc
NASDAQ:ATEC
Watchlist
Price: 9.22 USD 1.21%
Market Cap: 1.3B USD
Have any thoughts about
Alphatec Holdings Inc?
Write Note

Alphatec Holdings Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Alphatec Holdings Inc
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Alphatec Holdings Inc
NASDAQ:ATEC
Long-Term Debt
$525.9m
CAGR 3-Years
18%
CAGR 5-Years
59%
CAGR 10-Years
22%
Becton Dickinson and Co
NYSE:BDX
Long-Term Debt
$17.9B
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
17%
Boston Scientific Corp
NYSE:BSX
Long-Term Debt
$9.2B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Long-Term Debt
$13.3B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
15%
Abbott Laboratories
NYSE:ABT
Long-Term Debt
$12.8B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Alphatec Holdings Inc
Glance View

Market Cap
1.3B USD
Industry
Health Care

Alphatec Holdings Inc., often recognized under its brand ATEC, is a dynamic entity within the spinal solutions market. The company, based in Carlsbad, California, has passionately committed to transforming spinal surgeries, focusing on surgical innovation to solve the most persistent challenges faced by surgeons. ATEC started with a vision to shake up the staid, conventional spine surgery landscape by leveraging technology to improve surgical techniques and patient outcomes. This commitment to innovation is evident in its robust pipeline of products designed for various spinal disorders and conditions. By investing heavily in research and development, ATEC consistently brings to market cutting-edge solutions that align with its goal of revolutionizing surgical spine treatment. Its approach to problem-solving sets it apart: rather than an off-the-shelf attitude, ATEC works closely with surgeons to create tailored solutions that meet the individualized needs of their patients. The financial engine of Alphatec revolves around the commercial reach of its proprietary spinal hardware and biologics portfolio. The company taps into a growing demand for advanced spinal surgery technologies, channeling its expansive product line through its sales team and collaboration with distribution partners. Revenues primarily stem from product sales, where the integration of new technologies such as its AlphaInformatiX platform, an integrated software suite, enhances the surgical experience through real-time analytics and visualization, creating additional value for healthcare providers. By focusing on high-margin, innovative products, while continually expanding its distribution networks and scaling its operations to meet increasing demand, ATEC positions itself as an essential player with the potential for sustainable revenue growth in the competitive spine surgery market.

ATEC Intrinsic Value
12.88 USD
Undervaluation 28%
Intrinsic Value
Price

See Also

What is Alphatec Holdings Inc's Long-Term Debt?
Long-Term Debt
525.9m USD

Based on the financial report for Sep 30, 2024, Alphatec Holdings Inc's Long-Term Debt amounts to 525.9m USD.

What is Alphatec Holdings Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
22%

Over the last year, the Long-Term Debt growth was 4%. The average annual Long-Term Debt growth rates for Alphatec Holdings Inc have been 18% over the past three years , 59% over the past five years , and 22% over the past ten years .

Back to Top